Imatinib Completed Phase 1 / 2 Trials for Small Intestine Cancer / Cancer, Ovarian / Sarcomas / Endometrial Cancers / Gastrointestinal Stromal Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT00441155Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib